TORRENT PHARMACEUTICALS LTD
⚠️ High Risk
FEI: 3013644874 • Sikkim • INDIA
FEI Number
3013644874
Location
Sikkim
Country
INDIAAddress
32 No Middle Camp Nh-10east District Ganglok, , Sikkim, , India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/24/2025 | 66NDY06ARIPIPRAZOLE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II) | Division of Northeast Imports (DNEI) | |
| 9/9/2022 | 66NCE06ARIPIPRAZOLE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/21/2022 | 61TCA31DOMPERIDONE | Division of Southeast Imports (DSEI) | |
| 4/27/2022 | 62ODY14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II) | Division of Southeast Imports (DSEI) | |
| 12/17/2021 | 60SCY25RANITIDINE HYDROCHLORIDE (ANTACID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2021 | 64BDA24FUROSEMIDE (DIURETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/25/2020 | 61TCT31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/24/2020 | 61TCA31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/3/2020 | 62KCA08LOPERAMIDE HYDROCHLORIDE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/27/2020 | 60SCY28RANITIDINE (ANTACID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/6/2020 | 61TDY31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/18/2019 | 60SDA27RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/12/2019 | 61DCE99ANTI-ANGINAL, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/13/2019 | 61TCA31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/21/2018 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is TORRENT PHARMACEUTICALS LTD's FDA import refusal history?
TORRENT PHARMACEUTICALS LTD (FEI: 3013644874) has 15 FDA import refusal record(s) in our database, spanning from 9/21/2018 to 10/24/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. TORRENT PHARMACEUTICALS LTD's FEI number is 3013644874.
What types of violations has TORRENT PHARMACEUTICALS LTD received?
TORRENT PHARMACEUTICALS LTD has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about TORRENT PHARMACEUTICALS LTD come from?
All FDA import refusal data for TORRENT PHARMACEUTICALS LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.